LDN-27219 CANCER TREATMENT RESEARCH - AN OVERVIEW

LDN-27219 cancer treatment research - An Overview

Consensus sequence for tTG crosslinking substrates. Alignment of all glutamine-donor crosslinking substrates described inside the Transdab database demonstrates that apart from glutamine (Q at position 0), there is little to no favoritism for various residues at up to five positions just before or after the glutamine residue to be crosslinked. Dete

read more